高雄醫學大學圖書館 |

Language: English

Back

KRAS基因突變於接受regorafenib及FOLFIRI為救援治療的...

張琮琨

KRAS基因突變於接受regorafenib及FOLFIRI為救援治療的轉移性大腸直腸癌病人 = Role of kras mutations in patients with metastatic colorectal cancer who receive regorafenib plus folfiri as a salvage therapy

Record Type:	Language materials, printed : monographic
Paralel Title:	Role of kras mutations in patients with metastatic colorectal cancer who receive regorafenib plus folfiri as a salvage therapy
Author:	張琮琨,
Place of Publication:	[高雄市]
Published:	[著者];
Year of Publication:	民107[2018]
Description:	[40]頁圖 : 30公分;

KRAS基因突變於接受regorafenib及FOLFIRI為救援治療的轉移性大腸直腸癌病人 = Role of kras mutations in patients with metastatic colorectal cancer who receive regorafenib plus folfiri as a salvage therapy
張, 琮琨

KRAS基因突變於接受regorafenib及FOLFIRI為救援治療的轉移性大腸直腸癌病人 = Role of kras mutations in patients with metastatic colorectal cancer who receive regorafenib plus folfiri as a salvage therapy / 張琮琨(Tsung-Kun Chang)撰 - [高雄市] : [著者], 民107[2018]. - [40]頁 ; 圖 ; 30公分.
含參考書目.

KRAS基因突變於接受regorafenib及FOLFIRI為救援治療的轉移性大腸直腸癌病人 = Role of kras mutations in patients with metastatic colorectal cancer who receive regorafenib plus folfiri as a salvage therapy
LDR:00913nam0 2200193 450 001 313351
005 20181002095313.0
010 0 $b 平裝
100 $a 20180913y2018 000y0engy0901 e
101 0 $a eng $d chi $d eng
102 $a tw
200 1 $a KRAS基因突變於接受regorafenib及FOLFIRI為救援治療的轉移性大腸直腸癌病人 $d Role of kras mutations in patients with metastatic colorectal cancer who receive regorafenib plus folfiri as a salvage therapy $f 張琮琨(Tsung-Kun Chang)撰
210 $a [高雄市] $c [著者] $d 民107[2018]
215 0 $a [40]頁 $c 圖 $d 30公分
314 $a 指導教授:王照元;共同指導教授:潘美仁
320 $a 含參考書目
328 $a 碩士論文--高雄醫學大學臨床醫學研究所碩士班
510 1 $a Role of kras mutations in patients with metastatic colorectal cancer who receive regorafenib plus folfiri as a salvage therapy
681 $a 008.415
700 1 $a 張 $b 琮琨 $3 431090
801 0 $a tw $b 華藝 $c 20180913